Metformine Accord

Metformin Hydrochloride, the active ingredient in Metformine Accord, is a Biguanide presented as a tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood‑glucose control. GNH USA supplies Metformine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformine Accord is used in the management of the metabolic disorder that affects glucose regulation. - Type 2 diabetes mellitus: helps lower elevated blood glucose levels and improves glycaemic control.

Metformine Accord may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhoea. - Metallic taste: transient alteration of taste perception. - Weight loss: modest reduction in body weight.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening accumulation of lactate. - Vitamin B12 deficiency: may develop with long‑term therapy. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: abnormal liver enzymes in susceptible individuals.

Before initiating therapy, consider the following safety measures. - Renal function assessment: ensure adequate kidney clearance before prescribing. - Hepatic status review: avoid use in patients with significant liver disease. - Cardiovascular risk: monitor for signs of heart failure. - Pregnancy and lactation: weigh potential benefits against unknown risks. - Concomitant alcohol use: limit intake to reduce lactic acidosis risk. - Store at ambient temperature: keep below 25°C in the original container, protected from moisture.

Metformine Accord can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure. - Cimetidine: can increase metformin plasma concentrations. - Certain antiretrovirals (e.g., didanosine): raise risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal clearance of metformin. - Beta‑blockers: can mask hypoglycaemia symptoms. - ACE inhibitors or ARBs: monitor renal function when combined.